Sort
30,917 grants matching “tumor microenvironment”
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
$632,130Jeffrey Noebels · Baylor College Of Medicine · R01 · FY2020 · CA
Development of a cell-penetrating beta-catenin antagonist peptide as a therapeutic candidate for Wnt-driven breast cancer
$632,111Jim Rotolo · Sapience Therapeutics, Inc. · R44 · FY2024 · CA
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$632,109Nicholas C Denko · Ohio State University · R01 · FY2022 · CA
Core--Molecular Genetics
$631,979John Jr D. Shaughnessy · Univ Of Arkansas For Med Scis · P01 · FY2007 · CA
Exploring PSMA Biology in Tumor neovasculature
$631,933Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
CANCAN - ROCHESTER
$631,930Karen M Mustian · University Of Rochester · OT2 · FY2025 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$631,889Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevance
$631,853Emil Schueler · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeting dsRNA sensing and ADAR1 in melanoma
$631,778Jeffrey J. Ishizuka · Yale University · R37 · FY2025 · CA
Targeting dsRNA sensing and ADAR1 in melanoma
$631,778Jeffrey J. Ishizuka · Yale University · R37 · FY2024 · CA
Translational Pathology Core
$631,729Peter A Jones · University Of Southern California · P30 · FY2014 · CA
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
$631,543Karl T Kelsey · Brown University · R01 · FY2024 · CA
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
$631,495Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2019 · CA
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy
$631,410Melissa J Suter · Massachusetts General Hospital · R01 · FY2025 · CA
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$631,336Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Extracellular pH mapping as therapeutic readout of drug delivery in glioblastoma
$631,151Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2017 · EB
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
$631,104Russell William Jenkins · Massachusetts General Hospital · R37 · FY2023 · CA
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$631,075Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors
$631,007Andras A. Heczey · Baylor College Of Medicine · R01 · FY2025 · CA
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence
$630,987Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2024 · NS
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
$630,846Huang Chiao Huang · Univ Of Maryland, College Park · R01 · FY2025 · CA
The role of the tumor biofilm in determining tissue tropism
$630,835Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cancer detection technology
$630,817Wen-Tien Chen · Vitatex, Inc. · R42 · FY2007 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
$630,802Timothy R Donahue · University Of California Los Angeles · R01 · FY2021 · CA
The CCK-B receptor signaling pathway as a driver of pancreatic cellular plasticity and carcinogenesis
$630,773Jill P Smith · Georgetown University · R01 · FY2025 · CA